Inequality of opportunities in health in France: a first pass
β Scribed by Alain Trannoy; Sandy Tubeuf; Florence Jusot; Marion Devaux
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 295 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1057-9230
- DOI
- 10.1002/hec.1528
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
This article analyses the role played by childhood circumstances, especially social and family background in explaining health status among older adults. We explore the hypothesis of an intergenerational transmission of health inequalities using the French part of SHARE. As the impact of both social background and parents' health on health status in adulthood represents circumstances independent of individual responsibility, this study allows us testing the existence in France of inequalities of opportunity in health related to family and social background. Empirically, our study relies on tests of stochastic dominance at first order and multivariate regressions, supplemented by a counterfactual analysis to evaluate the longβlasting impact of childhood conditions on inequality in health. Allocating the best circumstances in both parents' socioeconomic status and parents' health reduces inequality in health by an impressive 57% using the Gini coefficient. The mother's social status has a direct effect on the health of her offspring. By contrast, the effect on descendant's health from their father's social status is indirect only, which goes through the descendant's social status as an adult. There is also a strong effect of the father vital status on health in adulthood, revealing a selection effect. Copyright Β© 2009 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract This paper proposes an empirical implementation of the concept of inequality of opportunity in health and applies this to data from the UK National Child Development Study. Drawing on the distinction between __circumstance__ and __effort__ variables in John Roemer's work on equality of
## Patients and Methods Role of the study sponsor. Eli Lilly had no role in the study design, data collection, analysis, or preparation or review of the manuscript, or the decision to submit the manuscript for publication. ## Patient population. Following institutional review board approval, we
The peroral (po) bioavailability of nifedipine is reported to range from about 45 to 58% in the rat; this compares favourably to human beings. The metabolism of nifedipine is similar in rats and humans (oxidation of the dihydropyridine ring), with the liver believed to be solely responsible for the